| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Alcon Research |
| Information provided by: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT00314158 |
Purpose
The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
| Condition | Intervention | Phase |
|
Open-Angle Glaucoma Ocular Hypertension |
Drug: Brinzolamide 1%/Timolol 0.5%, Brinzolamide 1%, Timolol 0.5% |
Phase III |
| Genetics Home Reference related topics: | early-onset glaucoma |
| MedlinePlus related topics: | Glaucoma High Blood Pressure |
| ChemIDplus related topics: | Azopt Timolol Timolol maleate |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations More Information
| Study ID Numbers: | C-05-24 |
| First Received: | April 10, 2006 |
| Last Updated: | February 29, 2008 |
| ClinicalTrials.gov Identifier: | NCT00314158 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|
